ALC Alcon Inc.

63.13USD+0.21%Mkt Cap: 30.52B $P/E: 47.83

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics…

Key Statistics

Company
Market Cap30.52B USD
Enterprise Value34.39B USD
Revenue (TTM)10.86B USD
Gross Profit5.75B USD
Net Income (TTM)980.00M USD
Revenue/Share22.21 USD
Last Price63.13 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees25.0K
CountryUS
SectorHealthcare
IndustryMedical Instruments & Supplies
ISIN—
Valuation
P/E (Trailing)47.83
P/E (Forward)15.94
PEG1.15
EV/EBITDA14.30
EV/Revenue3.17
P/S2.81
P/B1.41
EPS (TTM)1.32
EPS (Forward)3.97
52W Range
61.835% of range87.64
52W High87.64 USD
52W Low61.83 USD
Profitability
Gross Margin55.24%
Oper. Margin14.63%
EBITDA Margin22.13%
Profit Margin9.42%
ROE4.45%
ROA3.11%
Growth
Revenue Growth8.70%
Earnings Growth—
Cash Flow & Leverage
Operating CF2.27B USD
CapEx (TTM)663.00M USD
FCF Margin11.72%
FCF Yield4.17%
Net Debt3.84B USD
Net Debt/EBITDA1.60
Balance Sheet
Debt/Equity0.02
Current Ratio2.09
Quick Ratio1.12
Book Value/Sh44.67 USD
Cash/Share3.01 USD
Dividends
Fwd Div Rate0.36 USD
Trail. Div Rate0.35 USD
Div. Yield0.56%
5Y Avg Yield0.28%
Payout Ratio26.56%
Ex-Div DateMay 6, 2026
Pay DateMay 7, 2026
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)84.45 USD
Upside (mean)+33.8%
Target Range62.00 USD – 103.00 USD
62.00+33.8% to mean103.00
# Analysts15
Ownership
Shares Out.483.40M
Float481.83M
Insiders0.20%
Institutions63.57%
Short Interest
Short Ratio13.0d
Short % Out.3.62%
Shares Short17.49M
Short (prev mo.)11.87M
Technical
SMA 5069.44 (-9.1%)
SMA 20073.19 (-13.7%)
Beta0.73
S&P 52W Chg15.78%
Avg Vol (30d)1.61M
Avg Vol (10d)1.73M
Technical Indicators
RSI (14)31.9
MACD-1.6193
MACD Signal-1.5915
MACD Hist.-0.0278
BB Upper67.63 USD
BB Middle64.99 USD
BB Lower62.35 USD
BB Width8.12%
ATR (14)1.126 USD
Vol Ratio (20d)0.62x